Recently, hydralazine combined with isosorbide dinitrate has been reported
to reduce cardiovascular mortality more than conventional
therapyinAfricanAmericanswithsevereheartfailure
67
and
historically more than the same therapy in Caucasian Americans,
68
althoughthefactorscontributingtothisethnicdifference have not been defined clearly.